发明名称 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
摘要 Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.
申请公布号 US9498452(B2) 申请公布日期 2016.11.22
申请号 US201514727260 申请日期 2015.06.01
申请人 Sunovion Pharmaceuticals Inc. 发明人 Jerussi Thomas;Fang Qun Kevin;Currie Mark G.
分类号 A61K31/135;C07C211/42 主分类号 A61K31/135
代理机构 Heslin, Rothenberg, Farley & Mesiti P.C. 代理人 Heslin, Rothenberg, Farley & Mesiti P.C.
主权项 1. A method for treating autism, comprising administering to a patient in need of treatment for autism a therapeutically effective amount of a compound of formula PQ: or a salt thereof.
地址 Marlborough MA US